ABBV Jan 2025 80.000 call
| Previous close | 69.61 |
| Open | 69.61 |
| Bid | 67.10 |
| Ask | 67.85 |
| Strike | 80.00 |
| Expiry date | 2025-01-17 |
| Day's range | 69.61 - 69.61 |
| Contract range | N/A |
| Volume | |
| Open interest | 23 |
Motley Fool3 High-Yielding Dividend Growth Stocks That Have Increased Their Payouts by 50% in 5 Years
If you're investing in a dividend stock, there's more than just the yield and the payout ratio to consider. It's also important to look at dividend increases -- whether the company has been making them in the past and is likely to continue doing so in the future. Three great dividend growth stocks to consider owning right now are AbbVie (NYSE: ABBV), McDonald's (NYSE: MCD), and Comcast (NASDAQ: CMCSA).
PR NewswireAbbVie to Host Third-Quarter 2023 Earnings Conference Call
AbbVie (NYSE: ABBV) will announce its third-quarter 2023 financial results on Friday, October 27, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie's Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.
PR NewswireAllergan Aesthetics and Girls Inc. Partner to Speed the Entry of Young Women into Positions of Leadership in the STEM Field
Today Allergan Aesthetics, an AbbVie company, announces its fifth year of partnership with Girls Inc., this year supporting Project Accelerate, a program addressing inequality in the workplace that aims to accelerate young women's trajectories through college and career entry. The Allergan Aesthetics effort will focus specifically on leadership paths in STEM (science, technology, engineering, and math).
